Life sciences and healthcare companies represent the largest sector in the U.S. economy. Given the importance of this sector, there is increasing demand for financial evaluation of both public and privately held companies. At the same time, an accurate assessment is particularly difficult given the shifting business models, the current economy, intellectual property issues, continuous innovation in the industry, the changing population demographics, quality problems and involvement of the government … Read more »

Life sciences and healthcare companies represent the largest sector in the U.S. economy. Given the importance of this sector, there is increasing demand for financial evaluation of both public and privately held companies. At the same time, an accurate assessment is particularly difficult given the shifting business models, the current economy, intellectual property issues, continuous innovation in the industry, the changing population demographics, quality problems and the government involvement in the health care debate, discussion and regulation. We examine the changing and increasingly problematic Review of Life Sciences and Healthcare companies that have obvious importance from a social perspective.
«Hide

from
Carol W. Carden,
Travis Chamberlain
John W. Hill
Source: Business Horizons
15 pages.
Release Date: 15, March 2010. Prod #: BH379-PDF-ENG
The Brave New World of appreciation Life Sciences and Healthcare Enterprises HBR case solution

[related_post themes="flat"]